PT Sejahteraraya Anugrahjaya Tbk (SRAJ.JK)
IDR 2260.0
(-3.42%)
IDR 2260.0
(-3.42%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 583.07 Billion IDR | 16.76% |
| 2022 | 521.5 Billion IDR | 9.99% |
| 2021 | 474.13 Billion IDR | 18.64% |
| 2020 | 399.63 Billion IDR | 22.78% |
| 2019 | 325.47 Billion IDR | 21.86% |
| 2018 | 267.09 Billion IDR | 33.45% |
| 2017 | 200.14 Billion IDR | 3.03% |
| 2016 | 194.26 Billion IDR | 26.1% |
| 2015 | 154.05 Billion IDR | 26.76% |
| 2014 | 121.53 Billion IDR | 9.45% |
| 2013 | 111.03 Billion IDR | 57.29% |
| 2012 | 70.59 Billion IDR | -3.73% |
| 2011 | 73.33 Billion IDR | 20.95% |
| 2010 | 60.62 Billion IDR | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 162.88 Billion IDR | 11.08% |
| 2024 Q1 | 159.19 Billion IDR | 5.01% |
| 2023 Q4 | 151.6 Billion IDR | -11.75% |
| 2023 Q2 | 157.94 Billion IDR | 23.8% |
| 2023 FY | 608.91 Billion IDR | 16.76% |
| 2023 Q3 | 171.79 Billion IDR | 8.77% |
| 2023 Q1 | 127.57 Billion IDR | 7.79% |
| 2022 Q2 | 132.23 Billion IDR | 4.47% |
| 2022 Q4 | 118.35 Billion IDR | -18.0% |
| 2022 FY | 521.5 Billion IDR | 9.99% |
| 2022 Q1 | 126.58 Billion IDR | -5.18% |
| 2022 Q3 | 144.33 Billion IDR | 9.15% |
| 2021 Q1 | 80.81 Billion IDR | -24.59% |
| 2021 FY | 474.13 Billion IDR | 18.64% |
| 2021 Q3 | 154.08 Billion IDR | 45.74% |
| 2021 Q4 | 133.49 Billion IDR | -13.36% |
| 2021 Q2 | 105.73 Billion IDR | 30.82% |
| 2020 Q4 | 107.17 Billion IDR | 14.99% |
| 2020 Q2 | 105.55 Billion IDR | 12.65% |
| 2020 Q3 | 93.2 Billion IDR | -11.7% |
| 2020 Q1 | 93.7 Billion IDR | -14.09% |
| 2020 FY | 399.63 Billion IDR | 22.78% |
| 2019 Q2 | 72.42 Billion IDR | 2.77% |
| 2019 FY | 325.47 Billion IDR | 21.86% |
| 2019 Q3 | 73.51 Billion IDR | 1.52% |
| 2019 Q4 | 109.07 Billion IDR | 48.36% |
| 2019 Q1 | 70.46 Billion IDR | -27.26% |
| 2018 Q3 | 52.79 Billion IDR | -17.3% |
| 2018 Q2 | 63.83 Billion IDR | 19.13% |
| 2018 Q1 | 53.58 Billion IDR | -8.41% |
| 2018 FY | 267.09 Billion IDR | 33.45% |
| 2018 Q4 | 96.88 Billion IDR | 83.52% |
| 2017 Q2 | 49.32 Billion IDR | 4.86% |
| 2017 Q1 | 47.03 Billion IDR | -14.21% |
| 2017 FY | 200.14 Billion IDR | 3.03% |
| 2017 Q4 | 58.5 Billion IDR | 29.22% |
| 2017 Q3 | 45.27 Billion IDR | -8.21% |
| 2016 Q2 | 46.18 Billion IDR | 4.26% |
| 2016 FY | 194.26 Billion IDR | 26.1% |
| 2016 Q4 | 54.82 Billion IDR | 12.01% |
| 2016 Q3 | 48.94 Billion IDR | 5.97% |
| 2016 Q1 | 44.3 Billion IDR | 11.81% |
| 2015 Q3 | 41.69 Billion IDR | 9.08% |
| 2015 Q2 | 38.22 Billion IDR | 10.77% |
| 2015 Q1 | 34.5 Billion IDR | 67.79% |
| 2015 FY | 154.05 Billion IDR | 26.76% |
| 2015 Q4 | 39.62 Billion IDR | -4.97% |
| 2014 Q1 | 27.02 Billion IDR | 116.03% |
| 2014 FY | 121.53 Billion IDR | 9.45% |
| 2014 Q4 | 20.56 Billion IDR | -53.86% |
| 2014 Q3 | 44.58 Billion IDR | 51.84% |
| 2014 Q2 | 29.36 Billion IDR | 8.65% |
| 2013 Q1 | 27 Billion IDR | 173.26% |
| 2013 Q2 | 34.68 Billion IDR | 28.46% |
| 2013 Q4 | 12.5 Billion IDR | -66.04% |
| 2013 Q3 | 36.83 Billion IDR | 6.18% |
| 2013 FY | 111.03 Billion IDR | 57.29% |
| 2012 Q2 | 20.72 Billion IDR | 10.13% |
| 2012 Q1 | 18.81 Billion IDR | -11.18% |
| 2012 FY | 70.59 Billion IDR | -3.73% |
| 2012 Q3 | 21.17 Billion IDR | 2.19% |
| 2012 Q4 | 9.88 Billion IDR | -53.33% |
| 2011 Q3 | 17.5 Billion IDR | 3.14% |
| 2011 Q2 | 16.96 Billion IDR | -4.01% |
| 2011 Q4 | 21.18 Billion IDR | 21.02% |
| 2011 FY | 73.33 Billion IDR | 20.95% |
| 2011 Q1 | 17.67 Billion IDR | 0.0% |
| 2010 FY | 60.62 Billion IDR | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| PT Bundamedik Tbk | 463.16 Billion IDR | -25.887% |
| PT Metro Healthcare Indonesia Tbk | 125.19 Billion IDR | -365.734% |
| PT Medikaloka Hermina Tbk | 1043.54 Billion IDR | 44.126% |
| PT Mitra Keluarga Karyasehat Tbk | 783.59 Billion IDR | 25.59% |
| PT Murni Sadar Tbk | 224.61 Billion IDR | -159.591% |
| PT Famon Awal Bros Sedaya Tbk | 293.68 Billion IDR | -98.54% |
| PT Royal Prima Tbk | 75.23 Billion IDR | -674.985% |
| PT Kedoya Adyaraya Tbk | 105.27 Billion IDR | -453.88% |
| PT Sarana Meditama Metropolitan Tbk | 393.56 Billion IDR | -48.152% |
| PT Siloam International Hospitals Tbk | 2519.46 Billion IDR | 76.857% |